Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration
about
Nitric oxide and peroxynitrite in health and diseaseSignaling pathways mediating a selective induction of nitric oxide synthase II by tumor necrosis factor alpha in nerve growth factor-responsive cellsRoles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.Abeta-induced vascular oxidative stress and attenuation of functional hyperemia in mouse somatosensory cortex.Alzheimer's proteins, oxidative stress, and mitochondrial dysfunction interplay in a neuronal model of Alzheimer's disease.NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease.The role of cholesterol and statins in Alzheimer's disease.Alzheimer's disease is a vasocognopathy: a new term to describe its nature.Vessel wall apoptosis and atherosclerotic plaque instability.Employing new cellular therapeutic targets for Alzheimer's disease: a change for the better?Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors.Identification of candidate genes for familial early-onset essential tremor.Endothelial nitric oxide synthase overexpression by neuronal cells in neurodegeneration: a link between inflammation and neuroprotection.Uncoupling of endothelial nitric oxide synthase in cerebral vasculature of Tg2576 mice.The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments.
P2860
Q24645400-341A3656-B055-4F63-A811-A5188FB13F89Q24814434-1F6729D4-9E16-4199-B801-D7914C2F5949Q30394816-C5300E71-5690-4C35-A7F4-F8435E01C406Q33201804-711ED107-D840-4CA8-96B6-13AB8070486BQ34127614-53F84177-2EE8-467C-8338-36EE6C103329Q34998995-7D8F8904-26AE-4B67-B2EA-5DAE6FE82170Q35638053-6DD2D798-3BBE-4A0D-BB94-B1F604C62CB3Q35841706-B0703D90-BEE6-4B10-BD54-71CB8D361CC7Q36062157-0467F544-C23D-4BB1-AD7D-FEA9AF47F9F6Q36266206-6F2DA6A8-A3D1-4050-BE1D-3943ED1E2B56Q36352348-D80E7491-F1F5-41FC-AA54-1AE474B1E58BQ37351438-03452316-E36F-4BEE-99DC-47FFAA1E50DAQ39990782-6C0F45B8-E54E-4A22-A858-865B1CAA2C8CQ42280005-286A88A6-0189-488E-B001-720C4BDED4D6Q55266969-FAB957E2-6B61-48D7-9533-F7F1B6909D92
P2860
Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration
description
2000 nî lūn-bûn
@nan
2000 թուականին հրատարակուած գիտական յօդուած
@hyw
2000 թվականին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Aberrant expression of nitric ...... ulopathy and neurodegeneration
@ast
Aberrant expression of nitric ...... ulopathy and neurodegeneration
@en
Aberrant expression of nitric ...... ulopathy and neurodegeneration
@nl
type
label
Aberrant expression of nitric ...... ulopathy and neurodegeneration
@ast
Aberrant expression of nitric ...... ulopathy and neurodegeneration
@en
Aberrant expression of nitric ...... ulopathy and neurodegeneration
@nl
prefLabel
Aberrant expression of nitric ...... ulopathy and neurodegeneration
@ast
Aberrant expression of nitric ...... ulopathy and neurodegeneration
@en
Aberrant expression of nitric ...... ulopathy and neurodegeneration
@nl
P2093
P1476
Aberrant expression of nitric ...... ulopathy and neurodegeneration
@en
P2093
S M de la Monte
P304
P356
10.1016/S0197-4580(99)00108-6
P407
P577
2000-01-01T00:00:00Z